Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Insulin-like Growth Factor Binding Protein-5 Modulates Muscle Differentiation through an Insulin-like Growth Factor-Dependent Mechanism

Payton L. James, Claire E. H. Stewart and Peter Rotwein
The Journal of Cell Biology
Vol. 133, No. 3 (May, 1996), pp. 683-693
Stable URL: http://www.jstor.org/stable/1617420
Page Count: 11
  • More info
  • Cite this Item
Insulin-like Growth Factor Binding Protein-5 Modulates Muscle Differentiation through an Insulin-like Growth Factor-Dependent Mechanism
Preview not available

Abstract

The insulin-like growth factor binding proteins (IGFBPs) are a family of six secreted proteins which bind to and modulate the actions of insulin-like growth factors-I and -II (IGF-I and -II). IGFBP-5 is more conserved than other IGFBPs characterized to date, and is expressed in adult rodent muscle and in the developing myotome. We have shown previously that C2 myoblasts secrete IGFBP-5 as their sole IGFBP. Here we use these cells to study the function of IGFBP-5 during myogenesis, a process stimulated by IGFs. We stably transfected C2 cells with IGFBP-5 cDNAs under control of a constitutively active promoter. Compared with vector-transfected control cells, C2 myoblasts expressing the IGFBP-5 transgene in the sense orientation exhibit increased IGFBP-5 levels in the extracellular matrix during proliferation, and subsequently fail to differentiate normally, as assessed by both morphological and biochemical criteria. Compared to controls, IGFBP-5 sense myoblasts show enhanced survival in low serum medium, remaining viable for at least four weeks in culture. By contrast, myoblasts expressing the IGFBP-5 antisense transcript differentiate prematurely and more extensively than control cells. The inhibition of myogenic differentiation by high level expression of IGFBP-5 could be overcome by exogenous IGFs, with des (1-3) IGF-I, an analogue with decreased affinity for IGFBP-5 but normal affinity for the IGF-I receptor, showing the highest potency. These results are consistent with a model in which IGFBP-5 blocks IGF-stimulated myogenesis, and indicate that sequestration of IGFs in the extracellular matrix could be a possible mechanism of action. Our observations also suggest that IGFBP-5 normally inhibits muscle differentiation, and imply a role for IGFBP-5 in regulating IGF action during myogenic development in vivo.

Page Thumbnails

  • Thumbnail: Page 
683
    683
  • Thumbnail: Page 
684
    684
  • Thumbnail: Page 
685
    685
  • Thumbnail: Page 
686
    686
  • Thumbnail: Page 
687
    687
  • Thumbnail: Page 
688
    688
  • Thumbnail: Page 
689
    689
  • Thumbnail: Page 
690
    690
  • Thumbnail: Page 
691
    691
  • Thumbnail: Page 
692
    692
  • Thumbnail: Page 
693
    693